- Filed
- Dec 12, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q3 2026 · Dec 12, 2025 | 88.37M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 74.04M sh |
| Shares Diluted | Q3 2026 · Oct 31, 2025 | 65.86M sh |
| Shares Diluted restated | Q3 2026 · Oct 31, 2024 | 54.06M sh |
| Shares Diluted restated | Q3 2026 · Oct 31, 2024 | 53.46M sh |
| Operating Cash Flow | Q3 2026 · Oct 31, 2025 | −$537.06K |
| Operating Cash Flow | Q3 2026 · Oct 31, 2024 | −$817.63K |
| Cash And Equivalents | Q3 2026 · Oct 31, 2025 | $436.52K |
| Cash And Equivalents | Q3 2026 · Jan 31, 2025 | $20.96K |
| Stockholders Equity | Q3 2026 · Oct 31, 2025 | −$1.31M |
| Stockholders Equity | Q3 2026 · Jul 31, 2025 | −$803.22K |
| Stockholders Equity | Q3 2026 · Apr 30, 2025 | −$1.39M |
| Stockholders Equity | Q3 2026 · Jan 31, 2025 | −$1.67M |
| Stockholders Equity | Q3 2026 · Oct 31, 2024 | −$1.97M |
| Stockholders Equity | Q3 2026 · Jul 31, 2024 | −$4.61M |
| Stockholders Equity | Q3 2026 · Apr 30, 2024 | −$2.66M |
| Stockholders Equity | Q3 2026 · Jan 31, 2024 | −$3.06M |
| Current Liabilities | Q3 2026 · Oct 31, 2025 | $1.76M |
| Current Liabilities | Q3 2026 · Jan 31, 2025 | $1.69M |
| Total Liabilities | Q3 2026 · Oct 31, 2025 | $1.79M |
| Total Liabilities | Q3 2026 · Jan 31, 2025 | $1.72M |
| Current Assets | Q3 2026 · Oct 31, 2025 | $472.63K |
| Current Assets | Q3 2026 · Jan 31, 2025 | $38.78K |
| Total Assets | Q3 2026 · Oct 31, 2025 | $478.95K |
| Total Assets | Q3 2026 · Jan 31, 2025 | $49.96K |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$0.01 |
| Eps Diluted | Q3 2026 · Oct 31, 2025 | −$0.02 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $0.02 |
| Eps Diluted | Q3 2026 · Oct 31, 2024 | $0.04 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$0.01 |
| Eps Basic | Q3 2026 · Oct 31, 2025 | −$0.02 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | $0.02 |
| Eps Basic | Q3 2026 · Oct 31, 2024 | $0.05 |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $333.6K |
| Sga Expense | Q3 2026 · Oct 31, 2025 | $431.69K |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $133.69K |
| Sga Expense | Q3 2026 · Oct 31, 2024 | $441.75K |
| Net Income | Q3 2026 · Oct 31, 2025 | −$559.64K |
| Net Income | Q3 2026 · Oct 31, 2025 | −$1.11M |
| Net Income | Q3 2026 · Jul 31, 2025 | −$218.71K |
| Net Income | Q3 2026 · Apr 30, 2025 | −$336.13K |
| Net Income | Q3 2026 · Oct 31, 2024 | $926.99K |
| Net Income | Q3 2026 · Oct 31, 2024 | $2.39M |
| Net Income | Q3 2026 · Jul 31, 2024 | $1.15M |
| Net Income | Q3 2026 · Apr 30, 2024 | $311.38K |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$461.79K |
| Operating Income | Q3 2026 · Oct 31, 2025 | −$850.69K |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$279.49K |
| Operating Income | Q3 2026 · Oct 31, 2024 | −$1.22M |